Shenzhen New Industries Biomedical (300832): Gewinn- und Verlustrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 48,18 Renminbi Yuan | 69 Renminbi Yuan | 37,5 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 66,066 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 785.718.785 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 4.576.759,483 | 4.535.404,458 | 3.929.655,726 | 3.046.955,733 | 2.545.415,315 | 2.194.966,536 | 1.681.588,076 | 1.383.610,984 | 1.140.564,742 | 922.504,78 | 731.682,197 | 545.276,457 | 378.122,833 | 258.082,366 |
Herstellungskosten | 1.407.242,272 | 1.266.534,91 | 1.063.651,828 | 906.203,204 | 734.303,394 | 500.868,989 | 337.003,224 | 265.476,552 | 243.272,598 | 195.542,277 | 178.086,587 | 130.754,909 | 104.912,572 | 84.709,689 |
Bruttoergebnis | 3.169.517,211 | 3.268.869,548 | 2.866.003,897 | 2.140.752,528 | 1.811.111,921 | 1.694.097,547 | 1.344.584,852 | 1.118.134,432 | 897.292,144 | 726.962,503 | 553.595,61 | 414.521,548 | 273.210,261 | 173.372,678 |
▸ Brutto-Marge | 69,25% | 72,07% | 72,93% | 70,26% | 71,15% | 77,18% | 79,96% | 80,81% | 78,67% | 78,8% | 75,66% | 76,02% | 72,25% | 67,18% |
Betriebliche Aufwendungen | 1.362.066,991 | 1.157.687,708 | 970.585,842 | 637.133,802 | 673.684,629 | 595.534,392 | 445.660,591 | 310.364,678 | 267.444,339 | 226.022,719 | 283.760,823 | 140.448,047 | 112.972,706 | 88.644,1 |
Operativer Gewinn/Verlust | 1.807.450,22 | 2.111.181,84 | 1.895.418,055 | 1.503.618,726 | 1.137.427,292 | 1.098.563,155 | 898.924,261 | 807.769,754 | 629.847,805 | 500.939,784 | 269.834,787 | 274.073,501 | 160.237,555 | 84.728,578 |
▸ Operative Marge | 39,49% | 46,55% | 48,23% | 49,35% | 44,69% | 50,05% | 53,46% | 58,38% | 55,22% | 54,3% | 36,88% | 50,26% | 42,38% | 32,83% |
Zinsen (Netto) | 35.567,688 | 16.106,642 | 12.804,402 | 3.569,262 | 2.211,356 | 859,529 | 372,46 | -640,115 | 959,508 | 1.284,286 | -359,834 | -1.285,13 | -1.415,641 | -69,477 |
▸ Zinsausgaben | 530,512 | 2.523,204 | 2.601,193 | 1.857,316 | 1.481,305 | 1.149,739 | 266,657 | 1.214,524 | 482,782 | 372,581 | 359,834 | 1.285,13 | 1.415,641 | 69,477 |
▸ Zinseinnahmen | 36.098,2 | 18.629,846 | 15.405,595 | 5.426,578 | 3.692,661 | 2.009,268 | 639,118 | 574,409 | 1.442,29 | 1.656,867 | - | - | - | - |
Andere Ausgaben | -12.249,193 | 34.091,641 | 15.157,181 | 5.986,364 | 4.109,396 | 2.660,736 | 831,299 | -63,245 | 1.203,63 | -26.212,18 | -21.703,463 | -23.992,29 | -5.928,212 | -2.536,019 |
Gewinn vor Steuern | 1.855.267,1 | 2.093.196,841 | 1.893.065,276 | 1.501.201,624 | 1.135.529,252 | 1.096.761,948 | 898.465,422 | 807.192,884 | 629.603,683 | 528.436,25 | 291.178,416 | 296.780,661 | 164.750,126 | 87.195,12 |
Steueraufwand | - | 264.740,222 | 239.412,027 | 173.283,266 | 161.832,76 | 157.614,562 | 125.856,434 | 113.196,035 | 91.396,87 | 76.741,636 | 42.059,786 | 43.908,304 | 23.482,263 | 12.079,224 |
Minderheitenanteil | 235.014,897 | - | - | - | - | - | - | - | - | - | - | - | - | -12,668 |
Nettogewinn/-verlust | 1.620.252,203 | 1.828.456,619 | 1.653.653,249 | 1.327.918,358 | 973.696,492 | 939.147,386 | 772.608,988 | 693.996,849 | 538.206,813 | 451.694,614 | 249.118,63 | 252.872,357 | 141.267,863 | 75.128,564 |
▸ Netto-Marge | 35,4% | 40,32% | 42,08% | 43,58% | 38,25% | 42,79% | 45,95% | 50,16% | 47,19% | 48,96% | 34,05% | 46,38% | 37,36% | 29,11% |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.